192
picture, surgical approaches, and therapeutic
decision making regarding metastasis to the pos-
terior fossa is important background for the mod-
ern neurosurgical oncologist, and this knowledge
will only increase in utility throughout the com-
ing decades.
Acknowledgments We thank Kristin Kraus, MSc, for
editorial assistance and Jennie Williams, MA, for
illustrations.
References
- Gavrilovic IT, Posner JB. Brain metastases: epi-
demiology and pathophysiology. J Neuro-Oncol.
2005;75(1):5–14. - Lassman AB, DeAngelis LM. Brain metastases.
Neurol Clin. 2003;21(1):1–23. - Landis SH, Murray T, Bolden S, Wingo
PA. Cancer statistics, 1999. CA Cancer J Clin.
1999;49(1):8–31. - McDonald MW, McMullen KP. A new paradigm in
treatment of brain metastases. Curr Probl Cancer.
2015;39(2):70–88. - Delattre JY, Krol G, Thaler HT, Posner JB. Distribution
of brain metastases. Arch Neurol. 1988;45(7):741–4. - Batson OV. The function of the vertebral veins and
their role in the spread of metastases. Ann Surg.
1940;112(1):138. - Renaud S, Seitlinger J, Falcoz P-E, Schaeffer M,
Voegeli A-C, Legrain M, et al. Specific KRAS
amino acid substitutions and EGFR mutations pre-
dict site-specific recurrence and metastasis follow-
ing non-small-cell lung cancer surgery. Br J Cancer.
2016;115:346–53. - Kim M-J, Lee HS, Kim JH, Kim YJ, Kwon JH, Lee
J-O, et al. Different metastatic pattern according to the
KRAS mutational status and site-specific discordance
of KRAS status in patients with colorectal cancer.
BMC Cancer. 2012;12(1):347. - Hoshino A, Costa-Silva B, Shen T-L, Rodrigues
G, Hashimoto A, Mark MT, et al. Tumour exosome
integrins determine organotropic metastasis. Nature.
2015;527(7578):329–35. - Belal A Jr. Metastatic tumours of the temporal
bone. A histopathological report. J Laryngol Otol.
1985;99(9):839–46. - Greenberg HS, Deck MD, Vikram B, Chu FC, Posner
JB. Metastasis to the base of the skull: clinical find-
ings in 43 patients. Neurology. 1981;31(5):530–7. - Stark AM, Eichmann T, Mehdorn HM. Skull metas-
tases: clinical features, differential diagnosis, and
review of the literature. Surg Neurol. 2003;60(3):219–
25. discussion 25–6 - Vikram B, Chu FC. Radiation therapy for metastases to
the base of the skull. Radiology. 1979;130(2):465–8.
14. Bairey O, Kremer I, Rakowsky E, Hadar H, Shaklai
M. Orbital and adnexal involvement in systemic non-
Hodgkin’s lymphoma. Cancer. 1994;73(9):2395–9.
15. Harada S, Toya S, Iisaka Y, Ohtani M, Nakamura
Y. Basal skull metastasis of stomach cancer pre-
senting with Garcin’s syndrome – a case report. No
Shinkei Geka. 1987;15(7):765–9.
16. Weisenthal R, Frayer WC, Nichols CW, Eagle
RC. Bilateral ocular disease as the initial presen-
tation of malignant lymphoma. Br J Ophthalmol.
1988;72(4):248–52.
17. Laigle-Donadey F, Taillibert S, Martin-Duverneuil
N, Hildebrand J, Delattre JY. Skull-base metastases.
J Neuro-Oncol. 2005;75(1):63–9.
18. Svare A, Fossa SD, Heier MS. Cranial nerve dysfunc-
tion in metastatic cancer of the prostate. Br J Urol.
1988;61(5):441–4.
19. Morreale VM, Ebersold MJ, Quast LM, Parisi
JE. Cerebellar astrocytoma: experience with 54 cases sur-
gically treated at the Mayo Clinic, Rochester, Minnesota,
from 1978 to 1990. J Neurosurg. 1997;87(2):257–61.
20. Svien HJ, Baker HL, Rivers MH. Jugular fora-
men syndrome and allied syndromes. Neurology.
1963;13:797–809.
21. Graus F, Walker RW, Allen JC. Brain metastases in
children. J Pediatr. 1983;103(4):558–61.
22. Posner JB. Brain metastases: 1995. A brief review.
J Neuro-Oncol. 1996;27(3):287–93.
23. Moris G, Roig C, Misiego M, Alvarez A, Berciano
J, Pascual J. The distinctive headache of the occipital
condyle syndrome: a report of four cases. Headache.
1998;38(4):308–11.
24. Pascual J, Gutierrez A, Polo JM, Berciano J. Occipital
condyle syndrome: presentation of a case. Neurologia.
1989;4(8):293–5.
25. Seaman EK, Ross S, Sawczuk IS. High incidence of
asymptomatic brain lesions in metastatic renal cell
carcinoma. J Neuro-Oncol. 1995;23(3):253–6.
26. Hochstenbag M, Twijnstra A, Wilmink J, Wouters E,
Ten Velde G. Asymptomatic brain metastases (BM) in
small cell lung cancer (SCLC): MR-imaging is useful
at initial diagnosis. J Neuro-Oncol. 2000;48(3):243–8.
27. Merchut MP. Brain metastases from undiagnosed sys-
temic neoplasms. Arch Int Med. 1989;149(5):1076–80.
28. Komiyama M, Yagura H, Baba M, Yasui T, Hakuba
A, Nishimura S, et al. MR imaging: possibility of tis-
sue characterization of brain tumors using T1 and T2
values. AJNR Am J Neuroradiol. 1987;8(1):65–70.
29. Lignelli A, Khandji AG. Review of imaging tech-
niques in the diagnosis and management of brain
metastases. Neurosurg Clin N Am. 2011;22(1):15–25.
30. Destian S, Sze G, Krol G, Zimmerman R, Deck
M. MR imaging of hemorrhagic intracranial neo-
plasms. AJR Am J Roentgenol. 1989;152(1):137–44.
31. Mintz AP, Cairncross JG. Treatment of a single brain
metastasis: the role of radiation following surgical
resection. JAMA. 1998;280(17):1527–9.
32. Brillman J, Valeriano J, Adatepe MH. The diagnosis
of skull base metastases by radionuclide bone scan.
Cancer. 1987;59(11):1887–91.
B.D. Weaver and R.L. Jensen